title: Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab.
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Tomonori
authors.initials: T
authors.lastname: Tadokoro
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Eri
authors.initials: E
authors.lastname: Keshino
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Akitaka
authors.initials: A
authors.lastname: Makiyama
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Takakazu
authors.initials: T
authors.lastname: Sasaguri
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Koichi
authors.initials: K
authors.lastname: Ohshima
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Harutaka
authors.initials: H
authors.lastname: Katano
authors.affiliation: From the Departments of Cardiology (T.T., E.K., M.M.), Hematology/Oncology (A.M.), and Pathology (T.S.), Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan; Department of Pathology (K.O.), Kurume University, Japan; and Department of Pathology (H.K.), National Institute of Infectious Diseases, Tokyo, Japan. masahiro-mohri@umin.ac.jp.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Mohri
mesh_terms: D000208:Acute Disease; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D001706:Biopsy; D002830:Choroid Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D008218:Lymphocytosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D009205:Myocarditis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000276:immunology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000074322:Antineoplastic Agents, Immunological; D005938:Glucocorticoids; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab
keywords: adverse events; heart failure; immune checkpoint inhibitor; melanoma; myocarditis